Randomized trial of a web-based intervention to address barriers to clinical trials

Neal J. Meropol*, Yu Ning Wong, Terrance Albrecht, Sharon Manne, Suzanne M. Miller, Anne Lederman Flamm, Al Bowen Benson, Joanne Buzaglo, Michael Collins, Brian Egleston, Linda Fleisher, Michael Katz, Tyler G. Kinzy, Tasnuva M. Liu, Seunghee Margevicius, Dawn M. Miller, David Poole, Nancy Roach, Eric Ross, Mark D. Schluchter

*Corresponding author for this work

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose: Lack of knowledge and negative attitudes have been identified as barriers to participation in clinical trials by patients with cancer.Wedeveloped Preparatory Education About Clinical Trials (PRE-ACT), a theory-guided, Web-based, interactive computer program, to deliver tailored video educational content to patients in an effort to overcome barriers to considering clinical trials as a treatment option. Patients and Methods: A prospective, randomized clinical trial compared PRE-ACT with a control condition that provided general clinical trials information produced by the National Cancer Institute (NCI) in text format. One thousand two hundred fifty-five patients with cancer were randomly allocated before their initial visit with an oncologist to PRE-ACT (n = 623) or control (n = 632). PRE-ACT had three main components: assessment of clinical trials knowledge and attitudinal barriers, values assessment with clarification back to patients, and provision of a video library tailored to address each patient's barriers. Outcomes included knowledge and attitudes and preparation for decision making about clinical trials. Results: Both PRE-ACT and control interventions improved knowledge and attitudes (all P < .001) compared with baseline. Patients randomly allocated to PRE-ACT showed a significantly greater increase in knowledge (P < .001) and a significantly greater decrease in attitudinal barriers (P < .001) than did their control (text-only) counterparts. Participants in both arms significantly increased their preparedness to consider clinical trials (P < .001), and there was a trend favoring the PRE-ACT group (P < .09). PRE-ACT was also associated with greater patient satisfaction than was NCI text alone. Conclusion: These data show that patient education before the first oncologist visit improves knowledge, attitudes, and preparation for decision making about clinical trials. Both text and tailored video were effective. The PRE-ACT interactive video program was more effective than NCI text in improving knowledge and reducing attitudinal barriers.

Original languageEnglish (US)
Pages (from-to)469-478
Number of pages10
JournalJournal of Clinical Oncology
Volume34
Issue number5
DOIs
StatePublished - Feb 10 2016

Fingerprint

Clinical Trials
Education
National Cancer Institute (U.S.)
Decision Making
Patient Education
Patient Satisfaction
Libraries
Neoplasms
Software
Randomized Controlled Trials

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Meropol, N. J., Wong, Y. N., Albrecht, T., Manne, S., Miller, S. M., Flamm, A. L., ... Schluchter, M. D. (2016). Randomized trial of a web-based intervention to address barriers to clinical trials. Journal of Clinical Oncology, 34(5), 469-478. https://doi.org/10.1200/JCO.2015.63.2257
Meropol, Neal J. ; Wong, Yu Ning ; Albrecht, Terrance ; Manne, Sharon ; Miller, Suzanne M. ; Flamm, Anne Lederman ; Benson, Al Bowen ; Buzaglo, Joanne ; Collins, Michael ; Egleston, Brian ; Fleisher, Linda ; Katz, Michael ; Kinzy, Tyler G. ; Liu, Tasnuva M. ; Margevicius, Seunghee ; Miller, Dawn M. ; Poole, David ; Roach, Nancy ; Ross, Eric ; Schluchter, Mark D. / Randomized trial of a web-based intervention to address barriers to clinical trials. In: Journal of Clinical Oncology. 2016 ; Vol. 34, No. 5. pp. 469-478.
@article{d27ec7149b124b5986b651a7bf2db08f,
title = "Randomized trial of a web-based intervention to address barriers to clinical trials",
abstract = "Purpose: Lack of knowledge and negative attitudes have been identified as barriers to participation in clinical trials by patients with cancer.Wedeveloped Preparatory Education About Clinical Trials (PRE-ACT), a theory-guided, Web-based, interactive computer program, to deliver tailored video educational content to patients in an effort to overcome barriers to considering clinical trials as a treatment option. Patients and Methods: A prospective, randomized clinical trial compared PRE-ACT with a control condition that provided general clinical trials information produced by the National Cancer Institute (NCI) in text format. One thousand two hundred fifty-five patients with cancer were randomly allocated before their initial visit with an oncologist to PRE-ACT (n = 623) or control (n = 632). PRE-ACT had three main components: assessment of clinical trials knowledge and attitudinal barriers, values assessment with clarification back to patients, and provision of a video library tailored to address each patient's barriers. Outcomes included knowledge and attitudes and preparation for decision making about clinical trials. Results: Both PRE-ACT and control interventions improved knowledge and attitudes (all P < .001) compared with baseline. Patients randomly allocated to PRE-ACT showed a significantly greater increase in knowledge (P < .001) and a significantly greater decrease in attitudinal barriers (P < .001) than did their control (text-only) counterparts. Participants in both arms significantly increased their preparedness to consider clinical trials (P < .001), and there was a trend favoring the PRE-ACT group (P < .09). PRE-ACT was also associated with greater patient satisfaction than was NCI text alone. Conclusion: These data show that patient education before the first oncologist visit improves knowledge, attitudes, and preparation for decision making about clinical trials. Both text and tailored video were effective. The PRE-ACT interactive video program was more effective than NCI text in improving knowledge and reducing attitudinal barriers.",
author = "Meropol, {Neal J.} and Wong, {Yu Ning} and Terrance Albrecht and Sharon Manne and Miller, {Suzanne M.} and Flamm, {Anne Lederman} and Benson, {Al Bowen} and Joanne Buzaglo and Michael Collins and Brian Egleston and Linda Fleisher and Michael Katz and Kinzy, {Tyler G.} and Liu, {Tasnuva M.} and Seunghee Margevicius and Miller, {Dawn M.} and David Poole and Nancy Roach and Eric Ross and Schluchter, {Mark D.}",
year = "2016",
month = "2",
day = "10",
doi = "10.1200/JCO.2015.63.2257",
language = "English (US)",
volume = "34",
pages = "469--478",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "5",

}

Meropol, NJ, Wong, YN, Albrecht, T, Manne, S, Miller, SM, Flamm, AL, Benson, AB, Buzaglo, J, Collins, M, Egleston, B, Fleisher, L, Katz, M, Kinzy, TG, Liu, TM, Margevicius, S, Miller, DM, Poole, D, Roach, N, Ross, E & Schluchter, MD 2016, 'Randomized trial of a web-based intervention to address barriers to clinical trials', Journal of Clinical Oncology, vol. 34, no. 5, pp. 469-478. https://doi.org/10.1200/JCO.2015.63.2257

Randomized trial of a web-based intervention to address barriers to clinical trials. / Meropol, Neal J.; Wong, Yu Ning; Albrecht, Terrance; Manne, Sharon; Miller, Suzanne M.; Flamm, Anne Lederman; Benson, Al Bowen; Buzaglo, Joanne; Collins, Michael; Egleston, Brian; Fleisher, Linda; Katz, Michael; Kinzy, Tyler G.; Liu, Tasnuva M.; Margevicius, Seunghee; Miller, Dawn M.; Poole, David; Roach, Nancy; Ross, Eric; Schluchter, Mark D.

In: Journal of Clinical Oncology, Vol. 34, No. 5, 10.02.2016, p. 469-478.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Randomized trial of a web-based intervention to address barriers to clinical trials

AU - Meropol, Neal J.

AU - Wong, Yu Ning

AU - Albrecht, Terrance

AU - Manne, Sharon

AU - Miller, Suzanne M.

AU - Flamm, Anne Lederman

AU - Benson, Al Bowen

AU - Buzaglo, Joanne

AU - Collins, Michael

AU - Egleston, Brian

AU - Fleisher, Linda

AU - Katz, Michael

AU - Kinzy, Tyler G.

AU - Liu, Tasnuva M.

AU - Margevicius, Seunghee

AU - Miller, Dawn M.

AU - Poole, David

AU - Roach, Nancy

AU - Ross, Eric

AU - Schluchter, Mark D.

PY - 2016/2/10

Y1 - 2016/2/10

N2 - Purpose: Lack of knowledge and negative attitudes have been identified as barriers to participation in clinical trials by patients with cancer.Wedeveloped Preparatory Education About Clinical Trials (PRE-ACT), a theory-guided, Web-based, interactive computer program, to deliver tailored video educational content to patients in an effort to overcome barriers to considering clinical trials as a treatment option. Patients and Methods: A prospective, randomized clinical trial compared PRE-ACT with a control condition that provided general clinical trials information produced by the National Cancer Institute (NCI) in text format. One thousand two hundred fifty-five patients with cancer were randomly allocated before their initial visit with an oncologist to PRE-ACT (n = 623) or control (n = 632). PRE-ACT had three main components: assessment of clinical trials knowledge and attitudinal barriers, values assessment with clarification back to patients, and provision of a video library tailored to address each patient's barriers. Outcomes included knowledge and attitudes and preparation for decision making about clinical trials. Results: Both PRE-ACT and control interventions improved knowledge and attitudes (all P < .001) compared with baseline. Patients randomly allocated to PRE-ACT showed a significantly greater increase in knowledge (P < .001) and a significantly greater decrease in attitudinal barriers (P < .001) than did their control (text-only) counterparts. Participants in both arms significantly increased their preparedness to consider clinical trials (P < .001), and there was a trend favoring the PRE-ACT group (P < .09). PRE-ACT was also associated with greater patient satisfaction than was NCI text alone. Conclusion: These data show that patient education before the first oncologist visit improves knowledge, attitudes, and preparation for decision making about clinical trials. Both text and tailored video were effective. The PRE-ACT interactive video program was more effective than NCI text in improving knowledge and reducing attitudinal barriers.

AB - Purpose: Lack of knowledge and negative attitudes have been identified as barriers to participation in clinical trials by patients with cancer.Wedeveloped Preparatory Education About Clinical Trials (PRE-ACT), a theory-guided, Web-based, interactive computer program, to deliver tailored video educational content to patients in an effort to overcome barriers to considering clinical trials as a treatment option. Patients and Methods: A prospective, randomized clinical trial compared PRE-ACT with a control condition that provided general clinical trials information produced by the National Cancer Institute (NCI) in text format. One thousand two hundred fifty-five patients with cancer were randomly allocated before their initial visit with an oncologist to PRE-ACT (n = 623) or control (n = 632). PRE-ACT had three main components: assessment of clinical trials knowledge and attitudinal barriers, values assessment with clarification back to patients, and provision of a video library tailored to address each patient's barriers. Outcomes included knowledge and attitudes and preparation for decision making about clinical trials. Results: Both PRE-ACT and control interventions improved knowledge and attitudes (all P < .001) compared with baseline. Patients randomly allocated to PRE-ACT showed a significantly greater increase in knowledge (P < .001) and a significantly greater decrease in attitudinal barriers (P < .001) than did their control (text-only) counterparts. Participants in both arms significantly increased their preparedness to consider clinical trials (P < .001), and there was a trend favoring the PRE-ACT group (P < .09). PRE-ACT was also associated with greater patient satisfaction than was NCI text alone. Conclusion: These data show that patient education before the first oncologist visit improves knowledge, attitudes, and preparation for decision making about clinical trials. Both text and tailored video were effective. The PRE-ACT interactive video program was more effective than NCI text in improving knowledge and reducing attitudinal barriers.

UR - http://www.scopus.com/inward/record.url?scp=84958765343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958765343&partnerID=8YFLogxK

U2 - 10.1200/JCO.2015.63.2257

DO - 10.1200/JCO.2015.63.2257

M3 - Article

C2 - 26700123

AN - SCOPUS:84958765343

VL - 34

SP - 469

EP - 478

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 5

ER -